Models of Adoptive T-Cell-Mediated Regression of Established Tumors

  • Robert J. North
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 13)


Most of the chapters in this volume deal with the physiology and protective functions of macrophages as revealed by in vitro assays. Evidence that activated macrophages can express tumoristatic or tumoricidal function in vitro has been accumulating for 15 years or so and has resulted in the suggestion (Adams and Snyderman, 1979) that macrophages play a role in protecting against neoplastic colonization. It might be inferred, on the basis of in vitro evidence, moreover, that macrophages have the potential to destroy an established growing tumor, provided ways could be found to cause these cells to acquire tumoricidal function in the tumor bed. There is evidence (Evans, 1972; Russel and McIntosh, 1977) that progressive tumors can contain surprisingly large numbers of macrophages. It also has been shown (Russel and McIntosh, 1977) that Moloney sarcomas undergoing spontaneous regression in syngeneic mice contain macrophages that, on isolation, can lyse tumor cells in vitro. However, because of the reductionistic nature of the evidence obtained, no number of results obtained with in vitro assays can permit the conclusion that macrophages destroy tumors in vivo. The same criticism can be leveled against evidence showing that tumor-sensitized cytolytic T cells and natural killer (NK) cells lyse tumor cells in vitro. Sooner or later experiments will have to be designed to determine whether any one of these types of host cells, in the absence of the others, can express tumoricidal function in vivo and destroy an established tumor. The best models to employ in an attempt to identify the ultimate effectors of tumor regression would be models of immunologically mediated regression of established tumors.


Spleen Cell Tumor Regression Adoptive Immunotherapy Established Tumor Passive Transfer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, D. O., and Snyderman, R., 1979, Do macrophages destroy nascent tumors? J. Natl. Cancer Inst. 62: 1341.PubMedGoogle Scholar
  2. Baldwin, R. W., and Pimm, M. V., 1973, BCG immunotherapy of a rat sarcoma, Br. J. Cancer 28: 281.PubMedCrossRefGoogle Scholar
  3. Bast, R. C., Bast, B. S., and Rapp, H. J., 1976, Critical review of previously reported animal studies of tumor immunotherapy with non-specific immunostimulants, J. Natl. Cancer Inst. 277: 60.Google Scholar
  4. Berendt, M. J., and North, R. J., 1980, T cell-mediated immunosuppression of anti-tumor immunity. An explanation for the progressive growth of an immunogenic tumor, J. Exp. Med. 151: 69.PubMedCrossRefGoogle Scholar
  5. Bonventre, P. F., Nickol, A. D., Ball, E. J., Michael, J. G., and Bubel, H. C., 1982, Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity, J. Reticuloendothel. Soc. 32: 25.PubMedGoogle Scholar
  6. Brunner, K. T., MacDonald, H. R., and Cerottini, J. C., 1981, Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating sarcoma virus-induced tumors, J. Exp. Med. 154: 362.PubMedCrossRefGoogle Scholar
  7. Dye, E. S., and North, R. J., 1981, T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases, J. Exp. Med. 154:1033.Google Scholar
  8. Dye, E. S., North, R. J., and Mills, C. D., 1981, Mechanisms of anti-tumor action of Corynebacterium parvum. 1. Potentiated tumor-specific immunity and its therapeutic limitations, J. Exp. Med. 154: 609.PubMedCrossRefGoogle Scholar
  9. Evans, R., 1972, Macrophages in syngeneic animal tumors, Transplantation 14: 468.PubMedCrossRefGoogle Scholar
  10. Fernandez-Cruz, E., Gilman, S. C., and Feldman, J. D., 1982, Immunotherapy of a chemically induced sarcoma in rats: Characterization of effector T cell subset and nature of sup pression, J. Immunol. 128: 1112.PubMedGoogle Scholar
  11. Fujimoto, S., Green, M. I., and Sehon, A. H., 1976, Regulation of immune response to tumor antigens. I. Immunosuppressor cells in tumor bearing hosts, J. Immunol. 116: 791.PubMedGoogle Scholar
  12. Glaser, M., 1979, Regulation of specific cell-mediated cytotoxic response against SV40induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice, J. Exp. Med. 149: 774.PubMedCrossRefGoogle Scholar
  13. Gorelik, E., 1983, Concomitant tumor immunity, Adv. Cancer Res. 9: 71.CrossRefGoogle Scholar
  14. Goto, M., Mitsuoka, A., Sugiyama, M., and Kitano, M., 1981, Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon, J. Exp. Med. 154: 204.PubMedCrossRefGoogle Scholar
  15. Hellström, K. E., Kant, J. A., and Tamerius, J. D., 1978, Regression and inhibition of sarcoma growth by interference with a radiosensitive T cell population, J. Exp. Med. 148: 799.PubMedCrossRefGoogle Scholar
  16. Lagrange, P. H., and Thickstun, P. M., 1979, In vivo antitumor activity at various forms of delayed-type hypersensitivity in mice, J. Natl. Cancer Inst. 62: 429.Google Scholar
  17. Loveland, B. E., McKenzie, I. F. C., 1982, Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection, Transplantation 33: 174.PubMedCrossRefGoogle Scholar
  18. Loveland, B. E., Hogarth, P. M., Ceredig, R. H., and McKenzie, I. F. C.,1982, Cells mediating graft rejection in the mouse. 1. Lyt-1 cells mediate graft rejection, J. Exp. Med. 153: 1044.CrossRefGoogle Scholar
  19. Mills, C. D., and North, R. J., 1983, Expression of passively transferred tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells, J. Exp. Med. 157: 1448.PubMedCrossRefGoogle Scholar
  20. Mills, C. D., North, R. J., and Dye, E. S., 1981, Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression, J. Exp. Med. 154: 621.PubMedCrossRefGoogle Scholar
  21. Nelson, D. S., Nelson, M., and Hopper, K. E., 1979, Mechanisms of resistance to syngeneic methylcholanthrene-induced fibrosarcomas, Adv. Exp. Med. Biol. 121B: 541.Google Scholar
  22. North, R. J., 1982, Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells, J. Exp. Med. 55: 1063.CrossRefGoogle Scholar
  23. North, R. J., 1984, y-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells, Cancer Immunol. Immunother. (in press).Google Scholar
  24. North R. J., and Bursuker, I., 1984, The generation and decay of the immune response to a progressive f ibrosarcoma, J. Exp. Med. (in press).Google Scholar
  25. North, R. J., and Kirstein, D. P., 1977, T cell-mediated concomitant immunity to syngeneic tumors. 1. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites, J. Exp. Med. 145: 275.PubMedCrossRefGoogle Scholar
  26. North, R. J., Dye, E. S., Mills, C. D. and Chandler, J. P., 1982, Modulation of antitumor immunity. Immunobiologic Approaches, Springer Semin. Immunopathol. 5: 193.Google Scholar
  27. Reinisch, C. L., and Andrew, S. L., and Schlossman, S. F., 1977, Suppressor cell regulation Adoptive T-Cell-Mediated Regression of Tumors 257 of tumor immunity: Abrogation by adult thymectomy,Proc. Natl. Acad. Sci. USA 74 (7): 2989.CrossRefGoogle Scholar
  28. Röllinghoff, M., Starzinski-Powitz, A., Pfizenmaier, K., and Wagner, H., 1977, Cyclophosphamide-sensitive T lymphocytes suppress in vivo generation of antigen-specific cytotoxic T lymphocytes, J. Exp. Med. 145: 455.PubMedCrossRefGoogle Scholar
  29. Rosenberg, S. A., and Terry, W. D., 1977, Passive immunotherapy of cancer in animals and man, Adv. Cancer Res. 25: 323.PubMedCrossRefGoogle Scholar
  30. Rotter, V., and Trainin, N., 1975, Inhibition of tumor growth in syngeneic chimeric mice mediated by a depletion of suppressor T cells, Transplantation 20: 68.PubMedCrossRefGoogle Scholar
  31. Russel, S. W., and McIntosh, A. T., 1977, Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing tumors, Nature 268: 69.CrossRefGoogle Scholar
  32. Smith, H. G., Harmell, R. P., Hanna, M. G., Zwilling, B. S., Zbar, B., and Rapp, H. J., 1977, Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells, J. Natl. Cancer Inst. 58: 1315.PubMedGoogle Scholar
  33. Tuttle, R. L., and North, R. J., 1975, Mechanisms of antitumor action of Corynebacterium parvum: Nonspecific tumor cell destruction at site of an immunologically mediated sensitivity reaction to C. parvum, J. Natl. Cancer Inst. 55: 1043.Google Scholar
  34. Zbar, B., Bernstein, I. D., Bartlett, G. L., Hanna, M. G., and Rapp, H. J., 1972, Immunotherapy of cancer: Regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of livingMycobacterium bovis, J. Natl. Cancer Inst. 49: 119.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Robert J. North
    • 1
  1. 1.Trudeau Institute, Inc.Saranac LakeUSA

Personalised recommendations